General Wellness
Acne
CBD exerts sebostatic and antiinflammatory effects on human sebocytes
The endocannabinoid system of the skin in health and disease
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes
via cannabinoid receptor-2-mediated signaling
Endocannabinoid signaling and epidermal differentiation
Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions
ALS (Amyotrophic Lateral Sclerosis)
Anorexia
Antibiotic Resistance
Arthritis
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
Involvement of the endocannabinoid system in osteoarthritis
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55
Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis
Asthma
The role of cannabinoids in inflammatory modulation of allergic respiratory disorders, inflammatory pain and ischemic stroke
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma
Activation of cannabinoid receptors prevents antigen-induced asthma-like reaction in guinea pigs
Endogenous cannabinoid receptor agonists inhibit neurogenic inflammations in guinea pig airways
Bronchodilator effect of delta1-tetrahydrocannabinol
Evaluation of serum cytokines levels and the role of CBD treatment in animal model of asthma
Atherosclerosis
Autoimmune Disease
Bipolar
Colitis & Crohn's Disease
CBD in inflammatory bowel diseases: a brief overview
CBD reduces intestinal inflammation through the control of neuroimmune axis
Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant
Cannabis sativa, is protective in a murine model of colitis
The effects of Delta-tetrahydrocannabinol and CBD alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis
Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice
Cannabinoids and the gut: New developments and emerging concepts
Endocannabinoids and the gastrointestinal tract
Cannabinoids and gastrointestinal motility: Animal and human studies
Diabetes
CBD lowers incidence of diabetes in non-obese diabetic mice
Neuroprotective and blood-retinal barrier-preserving effects of CBD in experimental diabetes
Cannabidiol arrests onset of autoimmune diabetes in NOD mice
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation
Cannabinoids alter endothelial function in the Zucker rat model of type 2 diabetes
The endocannabinoid system in obesity and type 2 diabetes
Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain
Endocrine disorders
Endocannabinoid system participates in neuroendocrine control of homeostasis
The emerging role of the endocannabinoid system in endocrine regulation and energy balance
Endocannabinoids in endocrine and related tumours
Role of the endocannabinoid system in food intake, energy homeostasis and regulation of the endocrine pancreas
The role of the endocannabinoid system in the neuroendocrine regulation of energy balance
Heart Disease
CBD as an anti-arrhythmic, the role of the CB1 receptors
Is the cardiovascular system a therapeutic target for CBD?
The effect of CBD on ischemia/reperfusion-induced ventricular arrhythmias
CBD protects against myocardial ischemic reperfusion injury
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
Oleamide: A fatty acid amide signaling molecule in the cardiovascular system?
Huntington's Disease (HD)
Irritable Bowel Syndrome (IBS)
Cannabidiol in inflammatory bowel diseases: A brief overview
CBD reduces intestinal inflammation through the control of neuroimmune axis
Therapeutic potential of cannabinoid-based drugs
CBD and the gut: New developments and emerging concepts
Endocannabinoids and the gastrointestinal tract
CBD and gastrointestinal motility
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis
Kidney Disease
Liver Disease
Migraines
Mood Disorders
Motion Sickness
Multiple Sclerosis (MS)
Nausea
Neurodegeneration
Molecular targets of Cannabidiol in neurological disorders
CBD: A promising drug for neurodegenerative disorders?
CBD for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid?
Cannabidiol, neuroprotection and neuropsychiatric disorders
Short-term effects of CBD after global hypoxia-ischemia in newborn piglets
CBD activates neuronal precursor genes in human gingival mesenchymal stromal cells
Neurological aspects of medical use of CBD
Modulation of astrocyte activity by cannabidiol, a nonpsychoactive cannabinoid
Obesity
OCD (Obsessive Compulsive Disorder)
Osteoporosis/Bone Health
CBD Enhances Fracture Healing and Stimulates Lysyl Hydroxylase Activity in Osteoblasts
Cannabinoid receptors as target for treatment of osteoporosis: A tale of two therapies
Cannabinoids and bone: Friend or foe?
Cannabinoids and the skeleton: From marijuana to reversal of bone loss
The endovanilloid/endocannabinoid system: A new potential target for osteoporosis therapy
Endocannabinoids and the regulation of bone metabolism
Cannabinoid receptors and the regulation of bone mass
Peripheral cannabinoid receptor, CB2, regulates bone mass
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors
Long-chain polyunsaturated fatty acids may mutually benefit both obesity and osteoporosis
Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family
Parkinson's Disease
Prion Disease (Mad Cow)
PTSD (Post Traumatic Stress Disorder)
The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD
Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear
Modulation of fear memory by dietary polyunsaturated fatty acids via cannabinoid receptors
The endocannabinoid system and extinction learning
Non-antidepressant long-term treatment in post-traumatic stress disorder
The Use of Medicinal Marijuana for Posttraumatic Stress Disorder: A Review
Bidirectional Effects of CBD on Contextual Fear Memory Extinction
Rheumatism
Schizophrenia
Cannabidiol as a potential treatment for psychosis
CBD enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
Medical use of cannabis. CBD: A new light for schizophrenia
A critical review of the antipsychotic effects of CBD: 30 years of a translational investigation
Peripheral endocannabinoid system dysregulation in first-episode psychosis
Cannabinoids and schizophrenia
Antipsychotic-like effects of cannabidiol and rimonabant
CBD monotherapy for treatment-resistant schizophrenia
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
Scleroderma
Cannabinoid Signaling in the Skin: Therapeutic Potential of the "C(ut)annabinoid" System.
The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders.
Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts.
EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis.Sickle Cell Anemia
CBD exerts sebostatic and anti-inflammatory effects on human sebocytes
The endocannabinoid system of the skin in health and disease
Epigenetic control of skin differentiation genes by phytocannabinoids
Attenuation of allergic contact dermatitis through the endocannabinoid system
Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus
Spinal Cord Injury
Weight Loss
Wellness
CBD: From an inactive cannabinoid to a drug with wide spectrum of action
CBD as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress
CBD: An overview of some pharmacological aspects
CBD: An overview of some chemical and pharmacological aspects
The endocannabinoid system as an emerging target of pharmacotherapy
Therapeutic potential of cannabinoid-based drugs
Targeting the endocannabinoid system with cannabinoid receptor agonists
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Therapeutic potential of cannabinoid-based drugs
Cannabinoids in clinical practice
Combined cannabinoid therapy via an oromucosal spray
Non-psychotropic plant cannabinoids
Care and feeding of the endocannabinoid system
An update on safety and side effects of CBD: A review of clinical data and relevant animal studies